These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18721063)

  • 21. Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa.
    Barth RE; Wensing AM; Tempelman HA; Moraba R; Schuurman R; Hoepelman AI
    AIDS; 2008 Oct; 22(16):2210-2. PubMed ID: 18832885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Logistics and models of implementing large-scale HIV treatment, care and support in Africa.
    Darkoh-Ampem E; Sargent J; Butler J
    J HIV Ther; 2006 Mar; 11(1):16-20. PubMed ID: 16706251
    [No Abstract]   [Full Text] [Related]  

  • 23. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
    Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
    Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the potential benefits of early initiation of ART: time to do a trial to find out.
    Phillips AN; Emery S
    Curr Opin HIV AIDS; 2009 May; 4(3):165-6. PubMed ID: 19532044
    [No Abstract]   [Full Text] [Related]  

  • 25. Women living with HIV in South Africa and their concerns about fertility.
    Nduna M; Farlane L
    AIDS Behav; 2009 Jun; 13 Suppl 1():62-5. PubMed ID: 19301114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 27. Steady growth in antiretroviral treatment provision by disease management and community treatment programmes.
    Johnson LF; McLeod HD
    S Afr Med J; 2007 May; 97(5):358-9. PubMed ID: 17599217
    [No Abstract]   [Full Text] [Related]  

  • 28. Gold Fields adds to AIDS program.
    AIDS Alert; 2003 Aug; 18(8):102. PubMed ID: 12921060
    [No Abstract]   [Full Text] [Related]  

  • 29. Despair and hope in rural South Africa: the story of the antiretroviral drugs that are changing lives.
    Greenall J
    AIDS; 2008 Oct; 22(16):F1-3. PubMed ID: 18832868
    [No Abstract]   [Full Text] [Related]  

  • 30. Inspiring rural health--a fierce and distant light.
    Bateman C
    S Afr Med J; 2006 Jul; 96(7):576-7. PubMed ID: 16909173
    [No Abstract]   [Full Text] [Related]  

  • 31. Research vulnerability: an illustrative case study from the South African mining industry.
    Horn L
    Dev World Bioeth; 2007 Dec; 7(3):119-27. PubMed ID: 18021116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Safer sex under antiretroviral therapy/].
    Winckler T
    Pharm Unserer Zeit; 2008; 37(6):446-7. PubMed ID: 18956354
    [No Abstract]   [Full Text] [Related]  

  • 33. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
    Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management--a single-center study in South Africa.
    Fabian J; Naicker S; Venter WD; Baker L; Naidoo S; Paget G; Wadee S
    Ethn Dis; 2009; 19(1 Suppl 1):S1-80-5. PubMed ID: 19484882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HIV therapy in poor countries].
    Holen Ø
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2414. PubMed ID: 17009419
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.
    Puthanakit T; Aurpibul L; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2009 Mar; 28(3):246-8. PubMed ID: 19165130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
    J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV in South Africa.
    Satoh S; Boyer E
    Lancet; 2019 Aug; 394(10197):467. PubMed ID: 31402024
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.